Formulation, development and in-vitro evaluation of mucoadhesive bilayered buccal patches of montelukast sodium

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue 2, 2012, Pages 484-497

  Soni, Rajeev ^a   Sagar, Gali Vidya ^b   Sharma, Pankaj ^c  

^a SINGHANIA UNIVERSITY   (India)

^b Veerayatan Institute of Pharmacy   (India)

^c JAIPUR NATIONAL UNIVERSITY   (India)

Author keywords

Carbopol 974P; Impermeable backing membrane; Montelukast sodium; Mucoadhesive buccal patch; Sodium carboxymethylcellulose

Indexed keywords

CARBOMER; CARBOXYMETHYLCELLULOSE; ETHYL CELLULOSE; LEUKOTRIENE RECEPTOR; MONTELUKAST;

ARTICLE; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG RELEASE; DRUG STABILITY; IN VITRO STUDY; MUCOADHESION; SCANNING ELECTRON MICROSCOPY;

EID: 84859955778     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. David Price, Stanley D. Musgrave, Lee Shepstone et al. Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy. The New England Journal of Medicine May 5, 2011; 364: 18.
2. Patil A, Aman Taqiuddin et al. Formulation and evaluation of mouth dissolving tablets of montelukast sodium. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2011; 2 Issue 3: 268.
3. Currie G.P. and McLaughlin K. The expanding role of leukotriene receptor antagonists in chronic asthma. Ann Allergy Asthma Immunol 2006; 97: 731-741.
4. Raghavendra Rao N.G, Suryakar V.B. Formulation and Evaluation of Montelukast Sodium Mucoadhesive Buccal Patches for Chronic Asthma Attacks. International Journal of Pharma and Bio Sciences 2010; 1: 2.
5. Ali J, Khar RK, Ahuja A. Formulation and characterization of a buccoadhesive erodible tablet for the treatment of oral lesions. Pharmazie 1998; 53: 329-334.
6. Manish Kumar, Garima Garg, Pushpendra Kumar et al. Design and in-vitro evaluation of mucoadhesive buccal films containing famotidine. International Journal of Pharmacy and Pharmaceutical Sciences 2010; 2(3): 86-90.
7. Nair MK, Chien YW. Development of anticandidal delivery systems: (II) Mucoadhesive devices for prolonged drug delivery in the oral cavity. Drug Dev Ind Pharm 1996; 22: 243-253.
8. Perioli L, Ambrogi V, Rubini D et al. Novel mucoadhesive buccal formulation containing metronidazole for the treatment of periodontal disease. J Control Release 2004; 95: 521-533.
9. Parodi B, Russo E, Caviglioli G, Cafaggi S, Bignardi G. Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride. Drug Dev Ind Pharm 1996; 22: 445-450.
10. Ali J, Khar RK, Ahuja A, Kalra R. Buccoadhesive erodible disk for treatment of oro-dental infections: Design and characterization. Int J Pharm 2002; 238: 93-103.
11. Ilango R, Kavimani S, Mullaicharam AR, Jayakar B. In vitro studies on buccal strips of glibenclamide using chitosan. Indian J Pharm Sci 1997; 59: 232-235.
12. Bremecker KD, Strempel H, Klein G. Novel concept for a mucosal adhesive ointment. J Pharm Sci 1984; 73: 548-52.
13. Shin SC, Bum JP, Choi JS. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int J Pharm 2000; 209: 37-43.
14. Nafee NA, Ismail FA, Boraie NA, Mortada LM. Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. Int J Pharm 2003; 264: 1-14.
15. Higuchi T, Connoras KA. Phase-solubility techniques. ADV Anal Chem Instrum 1965; 4: 117-210.
16. Martin A, Swarbrick J, Cammarata A. Physical Pharmacy. 3rd ed., New Delhi: Lippincott Williams & Wilkins 2001; 303.
17. Hegde DA, Hegde DD, Nagarsenker MS et al. Application of differential scanning calorimetry (DSC) to preformulation compatibility studies between chloroquine phosphate and tablet excipients. Ind. J. Pharm. Sci 1996; 58: 71-76.
18. Rafferty DW, Koenig JL. FTIR imaging for the characterization of controlled-release drug delivery systems. J. Control. Rel 2002; 83: 29-39.
19. Lopez CR, Portero A, Vila-Jato JL and Alonso MJ. Design and evaluation of chitosan/ethyl cellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control. Release 1998; 55:143-152.
20. Patel VM, Prajapati BG, and Patel MM. Effect of hydrophilic polymers on buccoadhesive Eudragit patches of propranolol hydrochloride using factorial design. AAPS Pharm SciTech 2007; 82: 45.
21. Nafee NA. et al. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride, Acta Pharm 2003; 53: 199-212.
22. Agarwal V, Mishra B, Design, Development, and Biopharmaceutical Properties of Buccoadhesive Compacts of Pentazocine. Drug Development and Industrial Pharmacy 1999; 25: 701-709.
23. Ahmed B. Eldin, Abdalla A. Shalaby and Maha El-Tohamy. Development and validation of a HPLC method for the determination of montelukast and its degradation products in pharmaceutical formulation using an experimental design. Acta Pharmaceutica Sciencia 2011; 53: 45-56.
24. Ibrahim A. Alsarra. Development of a stability indicating HPLC method for the determination of montelukast sodium in tablets and human plasma and its applications to pharmacokinetic and stability studies. Saudi Pharmaceutical Journal 2004; Vol. 12, No. 4: 136-143.
25. Koland M, Sandeep VP, Charyulu NR. Fast dissolving sublingual films of ondensetron hydrochloride effect of additives on in-vitro drug release and mucosal permeation. J Young Pharm 2010; 2 (3): 216-222.
26. Peh KK and Wong CF. Polymeric films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. J. Pharm. Pharmaceut. Sci. 1999; 2: 53-61.
27. Smart JD. An in-vitro assessment of some mucoadhesive dosage forms. Int. J. Pharm. 1991; 73: 69-74.
28. Nakamura F, Ohta R, Machida Y and Nagai T. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int J Pharm, 1996; 134: 173-181.
29. Kanig JL. Goodman H. Evaluative procedures for film forming materials used in pharmaceutical applications. J. Pharm. Sci. 1962; 51: 77-83.
30. Mathiowitz E, Chickering III DE, Lehr CM. Bioadhesive Drug Delivery System: Fundamentals, Novel Approaches, and Development, Marcel Dekker Series, 1999; 98: 551.
31. Aarifkhan MP, Madhuri AC, Bharti VB et al. Development and in-vitro evaluation of salbutamol sulphate mucoadhesive buccal patches. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3 (2): 39-44.
32. Krosmeyer R W, Gurny R, Doelkar E, Buri P, Peppas NA, Int. J. Pharm, 1987; 15: 25-35.
33. Shargel L, Andrew BC, "Applied Biopharmaceutics and Pharmacokinetics," Prentice Hall Int. Co., Appleton-Century-Crofts, 1992; New York.
34. Woolfson AD, McCafferty DF, McCarron PA, and Price JH. A mucoadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue. J. Control. Release. 1995; 35: 49-58.
35. Leung SS and Robinson JR. Polymer structure features contributing to mucoadhesion: II, J. Control. Rel., 1991; 12:187-194.
36. Bouckaert S and Remon JP. In-vitro bioadhesion of a buccal miconazole slow release tablet. J. Pharm. Pharmacol 1993; 45: 504-507.
37. Soni R, Singh S et al., In Vitro and in Vivo Evaluation of Buccal Bioadhesive Films Containing Salbutamol Sulphate., Chem. Pharm. Bull., 2010; 58(3): 307-311.
38. Balamurugan M, Saravanan VS, Ganesh P, Senthil SP, Hemalatha PV and Sudhir Pandya., Development and In-vitro Evaluation of Mucoadhesive Buccal Tablets of Domperidone., Research J. Pharm. and Tech. 2008; 1:4.
39. Jacky Dias R, Shamling Sakhare S, Krishnat Mali K., Design and Development of Mucoadhesive Acyclovir Tablet, Iranian Journal of Pharmaceutical Research 2009; 8 (4): 231-239.
40. Mohammed FA and Khedr H. Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slowrelease tablets containing miconazole. Drug Dev. Ind. Pharm 2003;29:321-337.
41. Ritger PL and Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release 1987; 5:23-36.
42. Peppas NA and Krosmeyer RW. Hydrogels in medicine and pharmacy: properties and applications, CRC, Boca Raton 1986; 109.
43. Panigrahi L, Pattnaik S, Ghosal SK, Acta Pol. Pharm 2004; 61: 351-360.